Loading...

Hormonal therapies in young breast cancer patients: when, what and for how long?

Breast cancer in young women (<40 years) is a rare and complex clinical and psychosocial condition, which deserves multidisciplinary and personalized approaches. In young women with hormone-receptor positive disease, 5 years of adjuvant tamoxifen, with or without ovarian suppression/ablation, is...

Full description

Saved in:
Bibliographic Details
Main Authors: Christinat, Alexandre, Di Lascio, Simona, Pagani, Olivia
Format: Artigo
Language:Inglês
Published: Pioneer Bioscience Publishing Company 2013
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3695542/
https://ncbi.nlm.nih.gov/pubmed/23819026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2013.05.25
Tags: Add Tag
No Tags, Be the first to tag this record!